Moderna and Merrill jointly developed skin cancer vaccine trials.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna and Merrill jointly developed skin cancer vaccine trials.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Moderna
American biotechnology company
-
Merrill
American investing and wealth management division of Bank of America
Nothing else this week.
Related events
- Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.
- Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine.
- Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.
- Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.
- Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.